# A Multicenter Phase 2a Clinical Study to Evaluate SIM0278 in Subjects With Active Lupus Nephritis

> **NCT07393451** · PHASE2 · NOT_YET_RECRUITING · sponsor: **Simcere Pharmaceutical Co., Ltd** · enrollment: 60 (estimated)

## Conditions studied

- Lupus Nephritis

## Interventions

- **DRUG:** SIM0278 injection

## Key facts

- **NCT ID:** NCT07393451
- **Lead sponsor:** Simcere Pharmaceutical Co., Ltd
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-03-31
- **Primary completion:** 2028-03-31
- **Final completion:** 2028-08-31
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2026-02-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07393451

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07393451, "A Multicenter Phase 2a Clinical Study to Evaluate SIM0278 in Subjects With Active Lupus Nephritis". Retrieved via AI Analytics 2026-05-29 from https://api.ai-analytics.org/clinical/NCT07393451. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*